From surgical procedure selection to multiscale imaging to use of the latest drugs, we present a list of 10 not-to-be-missed sessions at AES 2016.
Three new studies look at stroke and the impact of folic acid, music therapy, and air pollution.
Do lipid-lowering medications or low vitamin D levels in mid-life cause neurocognitive deficits? What effect does hypotension have on TBI outcomes?
Psychological stressors, air pollution, and cardiorespiratory fitness were some of the stroke and AF risk factors researchers investigated.
November news includes potential Alzheimer treatments, FDA approval of a device to prevent recurrent stroke, & a newly typified headache disorder.
Studies include a potential test for MS, a link between headaches and hypothyroidism, and a risk prediction scale for stroke patients.
Data blitz presentations at ANA 2016 featured studies on neuronal dysfunction and degeneration in ALS, Parkinson disease, transverse myelitis, & more.
Award-winning posters presented during the American Neurological Association Annual Meeting discussed risks in stroke, MS, and migraine.
Oct. news includes an approved deep brain stimulation system for movement disorders & biomarkers that improve risk assessment in atrial fibrillation.
Three new multiple sclerosis studies show the promise of two drugs, amiselimod and alemtuzumab, as treatments and one, arbaclofen, for spasticity.